Kaisa Health Group Holdings Limited announced the shareholders of the Company (the "Shareholders") and potential investors that, based on a preliminary assessment on the unaudited consolidated accounts of the Group for the year ended 31 December 2022 and the information currently available to the Board, the Group is expected to record a loss attributable to the owners of the Company in the range of HKD 110 million to HKD 130 million for the year ended 31 December 2022 as compared to the profit attributable to the owners of the Company in the amount of approximately HKD 2 million for the year ended 31 December 2021.